Casandra
Casandra Test Code QD99365Version 1 (DRAFT)
Performing Lab
Epstein‑Barr Viral Capsid Antigen (VCA) Antibody, IgA
Clinical Use
Order TestUse
VCA IgA titers ≥1:80 often indicate chronic or reactivated EBV infection, whereas titers of 1:10, 1:20, or 1:40 usually indicate past infection. Elevated titers are also found in most patients with nasopharyngeal carcinoma; titers decrease with successful treatment.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Indirect Immunofluorescence Assay)
Biomarkers
VCA IgA
AnalyteVCA IgA titer • Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)
Result Turnaround Time
2-4 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
1.0 mL
Minimum Volume
0.25 mL
Container
Plastic Vial, from Red Top Tube
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 30 days |
Related Tests
Other tests from different labs that may be relevant
Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgA
ARUP Laboratories
Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgG and IgA
ARUP Laboratories
Epstein-Barr Virus (EBV) (Viral Capsid Antigen [VCA] and Early Antigen-Diffuse [EA(D)]), IgG Antibody Profile
Labcorp
Epstein-Barr Virus (EBV) Antibodies to Viral Capsid Antigen (VCA), IgG
Labcorp
Epstein-Barr Virus (EBV) Antibodies to Viral Capsid Antigen (VCA), IgM
Labcorp
Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgM
ARUP Laboratories
Epstein-Barr Virus Antibody to Viral Capsid Antigen, IgG
ARUP Laboratories
Epstein-Barr Virus (EBV) Antibodies to Early Antigen-Diffuse [EA(D)], IgG
Labcorp
Epstein-Barr Virus Antibody to Early D Antigen (EA-D), IgG
ARUP Laboratories
Epstein-Barr Virus (EBV) Antibody Profile
Labcorp
